66 related articles for article (PubMed ID: 20002523)
1. Inhibition of Abeta aggregation and neurotoxicity by the 39-kDa receptor-associated protein.
Kerr ML; Gasperini R; Gibbs ME; Hou X; Shepherd CE; Strickland DK; Foa L; Lawen A; Small DH
J Neurochem; 2010 Mar; 112(5):1199-209. PubMed ID: 20002523
[TBL] [Abstract][Full Text] [Related]
2. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
[TBL] [Abstract][Full Text] [Related]
3. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's beta-amyloid.
Kanapathipillai M; Lentzen G; Sierks M; Park CB
FEBS Lett; 2005 Aug; 579(21):4775-80. PubMed ID: 16098972
[TBL] [Abstract][Full Text] [Related]
4. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.
Liu R; Yuan B; Emadi S; Zameer A; Schulz P; McAllister C; Lyubchenko Y; Goud G; Sierks MR
Biochemistry; 2004 Jun; 43(22):6959-67. PubMed ID: 15170333
[TBL] [Abstract][Full Text] [Related]
5. S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses.
Businaro R; Leone S; Fabrizi C; Sorci G; Donato R; Lauro GM; Fumagalli L
J Neurosci Res; 2006 Apr; 83(5):897-906. PubMed ID: 16477616
[TBL] [Abstract][Full Text] [Related]
6. The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptor.
Small DH; Maksel D; Kerr ML; Ng J; Hou X; Chu C; Mehrani H; Unabia S; Azari MF; Loiacono R; Aguilar MI; Chebib M
J Neurochem; 2007 Jun; 101(6):1527-38. PubMed ID: 17286584
[TBL] [Abstract][Full Text] [Related]
7. Amyloid-beta oligomers increase the localization of prion protein at the cell surface.
Caetano FA; Beraldo FH; Hajj GN; Guimaraes AL; Jürgensen S; Wasilewska-Sampaio AP; Hirata PH; Souza I; Machado CF; Wong DY; De Felice FG; Ferreira ST; Prado VF; Rylett RJ; Martins VR; Prado MA
J Neurochem; 2011 May; 117(3):538-53. PubMed ID: 21352228
[TBL] [Abstract][Full Text] [Related]
8. PP1 inhibition by Abeta peptide as a potential pathological mechanism in Alzheimer's disease.
Vintém AP; Henriques AG; da Cruz E Silva OA; da Cruz E Silva EF
Neurotoxicol Teratol; 2009; 31(2):85-8. PubMed ID: 19028567
[TBL] [Abstract][Full Text] [Related]
9. Proteasome-mediated effects on amyloid precursor protein processing at the gamma-secretase site.
Flood F; Murphy S; Cowburn RF; Lannfelt L; Walker B; Johnston JA
Biochem J; 2005 Jan; 385(Pt 2):545-50. PubMed ID: 15473868
[TBL] [Abstract][Full Text] [Related]
10. Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42).
Qin Z; Sun Z; Huang J; Hu Y; Wu Z; Mei B
Neurosci Lett; 2008 Oct; 444(3):217-21. PubMed ID: 18760331
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's amyloid beta-peptide (1-42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: an intriguing role for methionine 35.
Clementi ME; Pezzotti M; Orsini F; Sampaolese B; Mezzogori D; Grassi C; Giardina B; Misiti F
Biochem Biophys Res Commun; 2006 Mar; 342(1):206-13. PubMed ID: 16472763
[TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein and amyloid beta-peptide bind to ATP synthase and regulate its activity at the surface of neural cells.
Schmidt C; Lepsverdize E; Chi SL; Das AM; Pizzo SV; Dityatev A; Schachner M
Mol Psychiatry; 2008 Oct; 13(10):953-69. PubMed ID: 17726461
[TBL] [Abstract][Full Text] [Related]
13. Understanding the molecular basis for the inhibition of the Alzheimer's Abeta-peptide oligomerization by human serum albumin using saturation transfer difference and off-resonance relaxation NMR spectroscopy.
Milojevic J; Esposito V; Das R; Melacini G
J Am Chem Soc; 2007 Apr; 129(14):4282-90. PubMed ID: 17367135
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity.
Yip CM; Elton EA; Darabie AA; Morrison MR; McLaurin J
J Mol Biol; 2001 Aug; 311(4):723-34. PubMed ID: 11518526
[TBL] [Abstract][Full Text] [Related]
15. Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity.
Wilhelmus MM; Boelens WC; Otte-Höller I; Kamps B; de Waal RM; Verbeek MM
Brain Res; 2006 May; 1089(1):67-78. PubMed ID: 16635482
[TBL] [Abstract][Full Text] [Related]
16. Selective modulation of amyloid-beta peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Abeta levels.
Abdul-Hay SO; Edirisinghe P; Thatcher GR
J Neurochem; 2009 Nov; 111(3):683-95. PubMed ID: 19702658
[TBL] [Abstract][Full Text] [Related]
17. Galantamine inhibits beta-amyloid aggregation and cytotoxicity.
Matharu B; Gibson G; Parsons R; Huckerby TN; Moore SA; Cooper LJ; Millichamp R; Allsop D; Austen B
J Neurol Sci; 2009 May; 280(1-2):49-58. PubMed ID: 19249060
[TBL] [Abstract][Full Text] [Related]
18. Mortalin overexpression attenuates beta-amyloid-induced neurotoxicity in SH-SY5Y cells.
Qu M; Zhou Z; Xu S; Chen C; Yu Z; Wang D
Brain Res; 2011 Jan; 1368():336-45. PubMed ID: 20974113
[TBL] [Abstract][Full Text] [Related]
19. Indirubin-3'-monoxime inhibits beta-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells.
Zhang S; Zhang Y; Xu L; Lin X; Lu J; Di Q; Shi J; Xu J
Neurosci Lett; 2009 Jan; 450(2):142-6. PubMed ID: 19027827
[TBL] [Abstract][Full Text] [Related]
20. A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes.
Maezawa I; Hong HS; Wu HC; Battina SK; Rana S; Iwamoto T; Radke GA; Pettersson E; Martin GM; Hua DH; Jin LW
J Neurochem; 2006 Jul; 98(1):57-67. PubMed ID: 16805796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
